NewAmsterdam Pharma Corporation
NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on developing transformative therapies for cardiovascular disease and other lipid-related and cardiometabolic conditions. The company is advancing science-backed, patient-focused treatments, including its investigational CETP inhibitor obicetrapib, to help patients whose needs are not met by currently available lipid-lowering therapies.
NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on developing transformative therapies for cardiovascular disease and other lipid-related and cardiometabolic conditions. The company is advancing science-backed, patient-focused treatments, including its investigational CETP inhibitor obicetrapib, to help patients whose needs are not met by currently available lipid-lowering therapies.
Build your career on Magnet.me
Create a profile and receive connection requests from interested companies.
Jobs
Interesting to know
This company page was generated automatically and therefore features only limited information. Find out more about NewAmsterdam Pharma Corporation on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about NewAmsterdam Pharma Corporation on their company website: